Concepedia

Julie Laudeman

JL

Statistics

Publications

7

Citations

439

H-Index

7

Active since

2005

Affiliations

National Cancer Institute(Current)

Leidos (United States)

National Cancer Institute

Frederick National Laboratory for Cancer Research

Julie Laudeman is an author at National Cancer Institute specializing in oncology, pharmacology, and medicine.

Publications per year

2005–2024

7

Publications

7

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

Eric C. Polley, Mark W. Kunkel, David M. Evans et al. · JNCI Journal of the National Cancer Institute · 2016 · 173 citations · Full text

, , +17

3D Models of the NCI60 Cell Lines for Screening Oncology Compounds

Mike Selby, René Delosh, Julie Laudeman et al. · SLAS DISCOVERY · 2017 · 67 citations · Full text

, , +16

A high-throughput fluorescence–anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors

Vikas Rishi, Timothy Potter, Julie Laudeman et al. · Analytical Biochemistry · 2005 · 66 citations

, , +13

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression

Beverly A. Teicher, Eric C. Polley, Mark W. Kunkel et al. · Molecular Cancer Therapeutics · 2015 · 65 citations · Full text

, , +15

Exposure time versus cytotoxicity for anticancer agents

David M. Evans, Jianwen Fang, Thomas Silvers et al. · Cancer Chemotherapy and Pharmacology · 2019 · 35 citations · Full text

, , +14

1–5 of 7